JVMSX | LYRCX | JVMSX / LYRCX | |
Total Expense Ratio | 1.24 | 1.99 | 62% |
Annual Report Gross Expense Ratio | 1.25 | 2.88 | 43% |
Fund Existence | 14 years | 3 years | - |
Gain YTD | 9.399 | 13.807 | 68% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 1000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 23.9B | 1.13B | 2,123% |
Annual Yield % from dividends | 0.40 | 0.00 | - |
Returns for 1 year | -5.30 | 6.81 | -78% |
Returns for 3 years | 24.28 | 60.45 | 40% |
Returns for 5 years | 45.42 | N/A | - |
Returns for 10 years | 47.59 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
DIVO | 44.27 | 0.39 | +0.89% |
Amplify CWP Enhanced Dividend Income ETF | |||
RSDE | 21.45 | 0.12 | +0.58% |
FT Vest U.S. Eq Eql Wght Buffr ETF - Dec | |||
FLOW | 33.89 | 0.16 | +0.46% |
Global X U.S. Cash Flow Kings 100 ETF | |||
XHE | 79.50 | 0.21 | +0.26% |
SPDR® S&P Health Care Equipment ETF | |||
QCLN | 45.53 | -0.79 | -1.70% |
First Trust NASDAQ® Cln Edge® GrnEngyETF |